Kunal S. Mahajan

Mandi, HP, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 115 publications

Prevalence and Early Left Ventricular Outcomes of Occlusive Myocardial Infarction in Non-ST-Elevation Acute Coronary Syndrome: A Retrospective Observational Study.

Prevalence and Early Left Ventricular Outcomes of Occlusive Myocardial Infarction in Non-ST-Elevation Acute Coronary Syndrome: A Retrospective Observational Study.

Journal: Cureus

Published: July 28, 2026

Aromatase inhibitors, GnRH analogues and growth hormone for short stature with advanced bone age in adolescent boys: a Bayesian network meta-analysis.

Aromatase inhibitors, GnRH analogues and growth hormone for short stature with advanced bone age in adolescent boys: a Bayesian network meta-analysis.

Journal: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists

Published: July 20, 2026

Combination Pharmacotherapies for Obesity-Current Evidence and Future Directions.

Combination Pharmacotherapies for Obesity-Current Evidence and Future Directions.

Journal: Endocrinology, diabetes & metabolism

Published: July 08, 2026

Efficacy and safety of CETP inhibitors in patients with atherosclerotic cardiovascular disease: A systematic review and meta-analysis of randomized controlled trials.

Efficacy and safety of CETP inhibitors in patients with atherosclerotic cardiovascular disease: A systematic review and meta-analysis of randomized controlled trials.

Journal: Journal of cardiovascular pharmacology

Published: July 06, 2026

Beyond therapeutic maximalism: Prioritization and personalization in preventive therapies.

Beyond therapeutic maximalism: Prioritization and personalization in preventive therapies.

Journal: Progress in cardiovascular diseases

Published: June 01, 2026

Safety and efficacy of glucagon like peptide-1 receptor agonism-based therapies in end-stage renal disease: A systematic review and meta-analysis.

Safety and efficacy of glucagon like peptide-1 receptor agonism-based therapies in end-stage renal disease: A systematic review and meta-analysis.

Journal: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists

Published: May 25, 2026

Safety and Efficacy of Glucagon Like Peptide-1 Receptor Agonism-Based Therapies in End-Stage Renal Disease: A Systematic Review and Meta-Analysis.

Safety and Efficacy of Glucagon Like Peptide-1 Receptor Agonism-Based Therapies in End-Stage Renal Disease: A Systematic Review and Meta-Analysis.

Journal: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists

Published: May 25, 2026

Comparative Efficacy and Safety of Tirzepatide in Asian and Non-Asian Adults With Obesity Without Diabetes: A Systematic Review and Meta-Analysis.

Comparative Efficacy and Safety of Tirzepatide in Asian and Non-Asian Adults With Obesity Without Diabetes: A Systematic Review and Meta-Analysis.

Journal: Endocrinology, diabetes & metabolism

Published: May 18, 2026

Letter to the Editor: Vitamin D deficiency and post-transplant diabetes in kidney recipients - opportunity for risk stratification and intervention.

Letter to the Editor: Vitamin D deficiency and post-transplant diabetes in kidney recipients - opportunity for risk stratification and intervention.

Journal: World journal of nephrology

Published: April 30, 2026

Global Lipid Guidelines: More Aligned Than They Appear.

Global Lipid Guidelines: More Aligned Than They Appear.

Journal: Global heart

Published: April 29, 2026

Novel Amylin-Based Therapies for Weight Management in Adults With Overweight or Obesity Without Diabetes: A Network Meta-Analysis.

Novel Amylin-Based Therapies for Weight Management in Adults With Overweight or Obesity Without Diabetes: A Network Meta-Analysis.

Journal: Endocrinology, diabetes & metabolism

Published: April 22, 2026

From Failure to Promise: Obicetrapib and the Renaissance of Cholesteryl Ester Transfer Protein Inhibition in Atherosclerotic Cardiovascular Disease.

From Failure to Promise: Obicetrapib and the Renaissance of Cholesteryl Ester Transfer Protein Inhibition in Atherosclerotic Cardiovascular Disease.

Journal: Journal of the American Heart Association

Published: April 22, 2026

Showing 1-12 of 115

Last Updated: 09/26/2026